Condition: Leukemia, Other · Sponsor: Ohio State University Comprehensive Cancer Center
The overall objective is to develop a clinical data registry that can be used to facilitate research with the ultimate goal of reducing the morbidity and/or mortality and improving the quality of life of patients diagnosed or living with hairy cell leukemia. With approximately 1,000 new cases of this rare disease identified in the US each year, HCL represents 2% of all cases of leukemia in adults. Considering the rarity of this chronic leukemia, the Hairy Cell Leukemia Foundation (HCLF), in partnership with investigators from its Centers of Excellence, seeks to develop a registry to help researchers identify new trends in outcomes, recognize the most effective treatments, discover previously unknown complications of the disease, and design clinical trials for new therapies.
This description comes directly from the study's public registry record.
Hairy Cell Leukemia Research Data Registry · 614-685-4296 · HCLRegistry@osumc.edu
Elena Botoulas, BS · 614-685-0635
Always discuss trial participation with your own doctor first.
| University of Miami/Soffer Clinical Research Center | Miami, Florida, United States | Recruiting |
| Mount Sinai Medical Center of Florida | Miami Beach, Florida, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| University of Rochester /Wilmot Cancer Institute | Rochester, New York, United States | Recruiting |
| Ohio State University Comprehensive Cancer Center | Columbus, Ohio, United States | Recruiting |
| Peter MacCallum Cancer Center | Melbourne, Victoria, Australia | Recruiting |
| BC Cancer, Part of the Provincial Health Services Authority | Vancouver, Britsh Columbia, Canada | Recruiting |
| Cancer Care Manitoba | Winnipeg, Manitoba, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02560883